Exercise and Weight Loss Medication for Better Health
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a combination of exercise and a weight loss medication (tirzepatide) can help people with overweight or obesity lose weight and improve their health. It's a good fit if you are between 30 and 65, have a BMI of 30–40 (or 27–29.9 with a related health risk), and are generally healthy enough for medication and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 65 years old.
- Your body mass index (BMI) is between 30 and 40, or between 27 and 29.9 with a health condition like high blood pressure or high cholesterol.
- You are willing to take a weight loss medication and are healthy enough for it.
- You have your primary care doctor's approval to join the study.
- You do not have diabetes, serious heart disease, or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
This trial tests if the weight loss medication tirzepatide can help young adults (18–40) with obesity and high blood pressure lower their blood pressure. It compares standard care to weight loss with tirzepatide.
This trial tests a medicine called tirzepatide, given as an injection, to see if it can improve daily function and symptoms in people with a weak heart (heart failure with reduced ejection fraction) who also have obesity. Tirzepatide works on two natural hormones to help with weight and may also improve heart health.
This study tests if tirzepatide can improve heart and metabolic health in overweight or obese adults with congenital heart disease. It may offer a new treatment option for weight loss when lifestyle changes alone haven't worked.
This study tests whether combining a newer weight-loss medication (tirzepatide) with a structured exercise program helps improve muscle strength and function in people who are overweight or obese. Researchers will measure changes in muscle quality and physical fitness over time.
This study tests whether a type 2 diabetes medication (tirzepatide) combined with a supervised resistance training (weight lifting) program helps prevent muscle loss while losing weight. You will either receive the medication or a placebo, and all participants will follow a diet and exercise plan.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.